iBeat and Dr. Mehmet Oz To Launch Lifesaving Smartwatch

Mehmet Oz, called America’s Doctor by many, has joined with health tech startup iBeat to launch a breakthrough heart monitoring smartwatch that empowers people to live longer lives. The partnership with Dr. Oz will kick off with pre-orders for its iBeat Life Monitor – a watch that continuously monitors one’s heart for life threatening emergencies and notifies loved ones and emergency responders in such an event. A world renowned leader in cardiothoracic surgery, a transplant surgeon, and holder of eight patents, Dr. Oz has saved thousands of lives both in the operating room and by educating his millions of viewers. After seeing the massive impact potential of the iBeat technology in their San Francisco headquarters, Oz invested, partnered with, and joined on as Special Advisor to the company.

“The iBeat Life Monitor was designed to continuously measure and monitor one’s heart and potentially prevent fatal heart incidents,” said Dr. Oz, seven-time Emmy Award winning host of the nationally syndicated “The Dr. Oz Show.” “This medical-grade device not only provides users with a sense of safety and control over their own heart health – which is vital in the treatment and prevention of heart failure – but also allows their loved ones and family members to take a more observant role in their care as well. To make a positive impact on the health of others, I’ve learned that we need to make it easy to do the right thing. This device is not only a technological breakthrough that will be more effective than anything on the market, it fits into a person’s wardrobe with style and ease, making it simple to integrate its lifesaving properties in one’s everyday routine. As Special Advisor, I look forward to raising awareness around preventing life-threatening heart issues and highlighting a device that can truly save lives.”

The iBeat Life Monitor differentiates itself from other wearables on the market by continuously monitoring and analyzing user’s heart activity and instantly detecting the signs of oncoming cardiac arrest (a sudden cessation of heart function). If the device detects a life-threatening heart emergency, it will engage the user and ask if he or she is ‘OK.’ If the user selects ‘No’ or is unresponsive, iBeat will instantly alert the user’s loved ones and emergency responders in real-time, helping ensure immediate care delivery and potentially saving the user’s life.

The iBeat Life Monitor does not need a cell phone, mobile app, Bluetooth connectivity, or Wi-Fi to function. The device is fully cellular, while built-in GPS ensures the user’s loved ones and first response teams know exactly where the user is in an emergency. In such an instance, emergency contacts will get a text with a link showing where the user is and where they are in-transit so they can meet them at the hospital or nearby care center. Users will also have access to an online dashboard where they can see their daily, weekly, and monthly overall heart health (beats per minutes, heart pattern changes, etc.) and compare it to others within their age range. The device is also equipped with an Emergency-On-Demand button which, when long-pressed for two seconds, will allow users to reach out to their emergency contacts, or if needed, 911.

While the watch is primarily targeted at baby-boomers, especially those who live alone, and individuals with existing heart conditions, the device is receiving notable interest from younger adults and millennials who have parents and grandparents that could greatly benefit from the device. iBeat has already raised $1.5 million in funding from private investors and is looking to establish the market for the iBeat Life Monitor through pre-orders, as well as support the tooling and production line needed to bring the device to the masses.

“The early interest we’ve seen in iBeat has been remarkable,” said Ryan Howard, founder and CEO of iBeat. “We are excited to bring our device to the Indiegogo platform to drive even more awareness around the product and its ability to potentially save someone’s life. If you suffer a life-threatening heart incident such as sudden cardiac arrest, you have a 90% chance of dying without intervention. There are many devices on the market including diabetic monitors, heart-rate monitors, and other health monitoring solutions, but all these devices only passively monitor you. None of them actively monitor and analyze your heart health around-the-clock like the iBeat Life Monitor. Continual monitoring and quick intervention can mean the difference between life and death in emergency situations.”

Source: iBeat

ResMed Expands COPD Offering

ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study[i] regarding the benefits of home non-invasive ventilation (NIV). Portable oxygen therapy, remote monitoring technology and home NIV are key components of ResMed’s COPD management offering.

The HOT-HMV study shows that the addition of home NIV to home oxygen therapy improves admission-free survival in hypercapnic COPD patients (those with high levels of carbon dioxide in the blood) following a life-threatening exacerbation of COPD requiring acute NIV.1 This includes an increase in patients’ median (hospital) admission-free survival from 1.4 months in the group receiving HOT only, to 4.3 months in the group receiving HOT plus home NIV, with an adjusted hazard ratio of 0.49 (0.31-0.77); p=0.002.

ResMed home NIV solutions are also connected to AirView™, ResMed’s cloud-based patient management system, which ensures healthcare professionals can remotely identify patients in need of attention, make informed treatment decisions and deliver timely interventions. In addition to helping physicians better manage COPD patients on home NIV, AirView also enables home care providers to optimise business efficiencies and allows them to focus existing resources on high-value activities. Resmed’s cloud-connected ventilators provide peace of mind to patients and their families and help improve their overall experience living with COPD.

A press release can be found from ResMed website.

Philips and Qualcomm announce strategic collaboration to advance personalized connected health care

Royal Philips and Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc., agreed on a strategic technology collaboration to advance connected health across the health continuum — from healthy living and prevention to chronic care management and home care. The companies are teaming up to leverage each other’s respective leading capabilities – Philips’ leadership in connected health informatics and regulated health care cloud data management and analytics, and Qualcomm Life’s expertise in secure, medical-grade device connectivity and integration. This collaboration will enable both companies to offer care providers enhanced, scalable, connected care solutions and services within a secure global ecosystem.

As part of the collaboration, Qualcomm Life will leverage Philips HealthSuite as a global, secure, data management and storage solution for its medical-grade 2net Platform, allowing Qualcomm Life to tap into the value of health data through data normalization, aggregation and analytics. Qualcomm Life customers can now have direct access to build applications, integrate with electronic health record systems, store normalized data, run analytics, and manage authorization and consents in a compliant and secure environment.  

A press release can be found from Philips website.

Home use medical devices market in China

As the aged population base is growing rapidly in China, the demand of certain home use medical devices also increases sharply. Younger generation also focuses on prevention rather than treatment, when maintaining physical health is concerned. To fit the daily needs, more and more families in China keep devices like thermometer, blood pressure monitor, glucose meter, oxygen concentrator and etc. at home, young people are more comfortable with wearable devices which is in most cases connected to a smart phone.
 
In the Chinese home use medical device market, there is also a strong market trend of developing and deploying m-health products to replace the conventional products. The ‘Hardware-APP-Cloud’ module is adapted by more and more device manufacturers.
 
The market size of medical device in China is around RMB400 Billion by the end of 2014, but only 14% falls into home use device category. The share of home use devices will for sure expand as long as the strong market demand grows, and we can easily presume, that more and more innovative products will be available in the Chinese market in the coming years.